The document discusses the manufacturing process of parenteral preparations. It describes parenterals as sterile liquids or solids for injection or implantation. The manufacturing process involves planning, material management, production, quality control testing, filling, and packaging. Production areas are divided into strict zones based on cleanliness. Environmental controls and facility design aim to prevent contamination, with areas for filling, weighing, storage, and administration. Personnel flow and utility locations are also considered for efficiency.
A detailed study on every aspects of parenteral :- introduction, preformulation factors, essential requirements, vehicles and additives, isotonicity, production procedure, facilities, and controls, container and closure selection and finally the quality control evaluation of parenterals.
A detailed study on every aspects of parenteral :- introduction, preformulation factors, essential requirements, vehicles and additives, isotonicity, production procedure, facilities, and controls, container and closure selection and finally the quality control evaluation of parenterals.
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
Hard gelatin capsules - a detailed studyTeny Thomas
The presentation involves a descriptive study on hard gelatin capsules which includes the production of the hard gelatin capsule shell, size of the capsules, capsule filling machines and the finishing techniques. The presentation also involves the special techniques of capsule formulation and the quality control tests of hard gelatin capsules
Pharmaceutical aerosols have been playing a crucial role in the health and wellbeing of millions of people throughout the world for many years. These products include pressurized metered dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, sublingual’s, skin sprays (coolants, anaesthetics, etc.) and dental sprays. The technology’s continual advancement, the ease of use, and the more desirable pulmonary-rather-than-needle delivery for systemic drugs has increased the attraction for the pharmaceutical aerosol in recent years.
Many of the tests required for the evaluation of MDIs are similar to those used for other dosage forms. These include description, identification, and assay of the active ingredient; microbial limits; moisture content; net weight, degradation products and impurities (if any); extractable; and any other tests deemed appropriate for the active ingredient.
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
Hard gelatin capsules - a detailed studyTeny Thomas
The presentation involves a descriptive study on hard gelatin capsules which includes the production of the hard gelatin capsule shell, size of the capsules, capsule filling machines and the finishing techniques. The presentation also involves the special techniques of capsule formulation and the quality control tests of hard gelatin capsules
Pharmaceutical aerosols have been playing a crucial role in the health and wellbeing of millions of people throughout the world for many years. These products include pressurized metered dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, sublingual’s, skin sprays (coolants, anaesthetics, etc.) and dental sprays. The technology’s continual advancement, the ease of use, and the more desirable pulmonary-rather-than-needle delivery for systemic drugs has increased the attraction for the pharmaceutical aerosol in recent years.
Many of the tests required for the evaluation of MDIs are similar to those used for other dosage forms. These include description, identification, and assay of the active ingredient; microbial limits; moisture content; net weight, degradation products and impurities (if any); extractable; and any other tests deemed appropriate for the active ingredient.
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
Aseptic / sterile - “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
Validation of aseptic process should be designed to provide assurance through appropriate testing that all phases and activities of the process remain sterile and it is controlled within the predetermined parameters.
Drug product, container, and closure are subject to sterilization separately, and then brought together.
Advanced manufacturing is the use of innovative technology to improve products or processes It can be defined as “The rate of technology adaptation and the ability to use that technology to remain competitive and add value to the advanced manufacturing sectors” In advanced aseptic processes, direct contact of the open product with an operator wearing a conventional cleanroom garment is not allowed Isolators effectively provide a seal against the entry of external contaminants using air over-pressure.
Premises’ refers to the buildings and facilities where pharmaceutical processing is done. These places must comply with cGMP requirements.
Premises must be located in a site that is of a size suitable to house all the different departments. The nature of manufacturing and testing to be performed, the magnitude of the operation in terms of daily production levels, the number of products that will be processed, and the storage space required for raw material, in-process and finished goods are some of the important factors to be considered when choosing a location. Other factors such as availability of power, water, labor workforce, and closeness to transport hubs may also impact this decision. From the GMP point of view, the most important factor is the climatic condition and hygiene levels in the surroundings. Pharmaceutical premises must ideally be located away from polluting industries as otherwise, it will burden the air handling and water handling systems.
According to Schedule M of the Drugs and Cosmetics Rules, factory buildings must be situated in a place that avoids contamination risk from the external environment (for example from open drains, public lavatory, open sewage lines, or industry that produces gaseous fumes or strong odors or generates smoke, dust or other chemical emissions).
The building used must be designed, constructed, and maintained in a manner that permits drug production under hygienic conditions. It must be suitable for the operations being performed. The layout of the premises must be such that it reduces the risk of errors, and also avoids the buildup of dirt and cross-contamination that may affect drug product quality. Construction and layout of the building must allow for a sequential and logical flow of the production process and movement of personnel and materials. It must also permit regular cleaning, repair, and maintenance work without harming product quality.
The walls, ceilings, and floors of the building must be smooth and crack-free, easy to clean and disinfect. Surfaces must not shed particles; they must be kept smooth and without any open joints where dust can accumulate.
utitlities
The building must be supplied with adequate light, water, power supply, and ventilation and must be fitted with systems to maintain the temperature and humidity of different areas at desired levels. There must be arrangements to protect against the entry of pests, insects, rodents, etc.
The fittings, ducts, pipes, and ventilation points must be designed in such a way that they do not produce difficult-to-clean recesses. Such points must be located to be easily accessible for maintenance work without having to enter the manufacturing areas.
Episode 34 : Project Execution Part (5)
•Large components – used suitable cranes, usually are leased/rent
– electronically controllable by remote control
•Medium/Smaller components
hoists or fork‐lifts are used
are ordered to the building site at an early stage and intermediately stored there.
‐If possible, at the same time, during the assembly of main components, the assembly of medium/smaller components will begin.
‐Subcontractor is required to provide suitable packaging or tarpaulin cover
(cover for vessel opening such as nozzle, by means of plastic caps)
SAJJAD KHUDHUR ABBAS
Ceo , Founder & Head of SHacademy
Chemical Engineering , Al-Muthanna University, Iraq
Oil & Gas Safety and Health Professional – OSHACADEMY
Trainer of Trainers (TOT) - Canadian Center of Human
Development
This presentation contains general guidelines and basic requirements of manufacturing of sterile medicinal products. This presentation is useful for training to the people involved in manufacturing of sterile pharmaceuticals or medicines.
Episode 22 : PROJECT EXECUTION
•Large components – used suitable cranes, usually are leased/rent
– electronically controllable by remote control
•Medium/Smaller components
hoists or fork‐lifts are used
are ordered to the building site at an early stage and intermediately stored there.
‐If possible, at the same time, during the assembly of main components, the assembly of medium/smaller components will begin.
‐Subcontractor is required to provide suitable packaging or tarpaulin cover
(cover for vessel opening such as nozzle, by means of plastic caps)
SAJJAD KHUDHUR ABBAS
Chemical Engineering , Al-Muthanna University, Iraq
Oil & Gas Safety and Health Professional – OSHACADEMY
Trainer of Trainers (TOT) - Canadian Center of Human
Development
1. Malla reddy college of
pharmacy
Industrial pharmacy seminar
By
D. Himabindu
H.T.NO: 256213886006
2.
3. INTRODUCTION:
parenteral preparations are sterile,
pyrogen-free liquids (solutions, emulsions, or
suspensions) or solid dosage forms containing one
or more active ingredients, packaged in either
single-dose or multi-dose containers.
They are intended for administration by injection,
infusion, or implementation into the body.
Parenteral drugs are administrated directly into
veins, muscles or under the skin or more specialized
tissues such as the spinal cord.
4. TYPES: there are four main forms of parenteral
preparations:
• injections,
• intravenous infusions (large volume parenterals),
• powders for injections, and
• implants
certain injections and intravenous infusions may be
presented in the form of sterile concentrated
solutions, which must be suitably diluted before use.
5. OVERVIEW OF MANUFACTURING PROCESS OF
PARENTERALS
Planning &
scheduling
Material management
-Raw material & API
-Packaging material
Warehousing
Equipment &
facility Manufacturing
requirement
documentation
personal
Manufacturing
Bulk analysis
Sterilization
Aseptic filling
Q.C. Testing
Visual inspection
Finishing
Labeling &
packing
6. FLOW OF MATERIALS:-
Ingredients
vehicle
salute
Processing
equipment
Container
component
Compounding
of product
Cleaning
Cleaning
Filteration of
solutes
Sterilization
Sterilization
Filling Sealing Packaging
Product
storage
Diagram of flow of materials through the production department
7. [QUALITATIVE LAYOUT OF PARENTERAL MANUFACTURING]
Function
Area
Square meter Percentage
Production 11,094 45.1
Warehouse 7,606 30.9
Utility 1,716 4.1
Quality control 1,716 7.0
Administration 1,018 4.1
Maintenance 1,014 4.5
Employee services 1,014 4.1
Security 39 0.9
Total 24,607 100.0
8. 1.AREA PLANING AND ENVIRONMENTAL CONTROL:-
Area planning may be addressed by functional
groups ground this critical area with particular
attention given to maintaining cleanliness.
Functional groupings:-
Warehousing:-
o The storage of spare parts, air filters, change parts,
water treatment chemicals, office supplier, janitorial
supplies, uniforms, an so on may be handled as
central storage or individually by department.
o Finished product and certain raw materials need
special environmental storage conditions, such as,
temperature and humidity control.
9. Administrative areas :-
1) Administrative area planning requires careful
analysis of the direct and indirect
administrative requirements of a particular
plant.
2) Successively higher levels of supervision are
usually provided successively larger office
areas.
3) Some offices are individual, while some are
grouped in an “open area concept”,
10. ZONES AS PER GAZZETE OF INDIA:
1st.zones as per gazette of India
WHITE
GRAY BLACK
• White zone:- final step (filling of parenteral)
• Grey zone:- weighing, dissolution & filtration.
• Black zone:- storage, worst area from
contamination view point.
11. ENVIRONMENTAL CONTROL ZONE GROUPING :-
1st.zones as per the c GMP:-
• Zone 7:- Filling line
• Zone 6:- Filling area
• Zone 5:-Weighing, mixing & transfer area
• Zone 4:- Clean area
• Zone 3:- General production
• Zone 2:- Warehouse
• Zone 1:- Exterior
12. Zone 7:- filling line:-
The walls of the filling area are the last physical barrier to
the ingress of contamination, but within the filling area a
technique of contamination control known as laminar flow
may be considered as the barrier to contamination.
For aseptic filling
process
Sterilization and
Depyrogenation of containers
before filling, normally hot air
oven or autoclave.
Provision must be
made for
Filling requires
An aseptic environment with the
Inspection and packaging attendant support rooms
13. Zone 6:- filling area:-
Zone 6 is a distinct zone of the controlled
environment area for an aseptic filling process but
may not be distinct zone for non-aseptic filling
process.
Zone 5:- weighing, mixing, and transfer area:-
Zone 5 encompasses activities of “weighing,
mixing, filling or transfer operations” addressed by c
GMP section 212.81 which are not handled as zone
6 but which require a controlled environment.
Zone 4:- clean area:-
Activities in this may include washing and
preparations of equipment or accumulation and
sampling of filled product.
14. Zone 3:- general production and administration
:-
area:-
The third zone of environmental controls is formed
by the periphery of the general production area.
Only essential materials-handling equipment and
personnel.
Zone 2:- plant exterior:-
It is a base point from which to work in
determining the requirements for the various
control barriers.
Control zone 1 might include the maintenance of
sterile areas around the facility.
15. 2. WALL & FLOOR TREATMENT:
The design of filling areas or more generally,
controlled environment areas involves attention to
many seemingly minor details. The basic
cleanlability requirement includes smooth,
celanable walls, floors, ceilings, fixtures, and
partition exposed columns, wall studs, bracing,
pipes, and so on are unacceptable.
The need for cleanability also eliminates the
open floor system commonly used in the
microelectronics industry for laminar airflow rooms.
16. The goal of the designer, when creating the
details for the architectural finishes and joining
methods, is to eliminate all edges or surfaces within
the room where dirt may accumulate.
All inside walls must be finished;
Example: common methods of finish are block,
plaster, or gypsum board.
17. 3. LIGHTNING FIXTURES :
Lighting fixtures should be reduced flush with
the ceiling. Areas having a full HEPA ceiling
obviously cannot accommodate recessed lighting
fixtures. In these areas, fixtures are of a special
“tear drop” shape which minimizes disruption to
the laminar airflow pattern.
4. CHANGE ROOMS :
Personnel access to all controlled areas should
be through change rooms. Change rooms concepts
and layouts vary from single closet size rooms to
expensive multi-room complexes.
18. Entrance to a change area is normally
through vestibules whose doors are electrically
interlocked so that both cannot be opened
simultaneously, thus maintaining the necessary air
pressure differential to prevent the entry of
airborne contamination.
Upon entry into the change room wash skins
are provided for scrubbing hands and forearms.
Further control may be achieved by using
filtered and heated compressed air for drying to
reduce further particular potential.
19. After hands are dry, garments are taken
from dispensers and donned while moving across a
dressing bench.
As a final growing step, aseptic gloves are
put on and sanitized. Exit from the change room to
the controlled area is, like entrance, through an
interlocked vestibule.
20. Clothing dispenser hand dryer hand wash
Exit Glove dispenser Change bench entrance
Change room
21. 5. Personnel flow :-
The movement of personnel should be
planned during the design of individual plant areas.
Each individual production area may have a smooth
and efficient personnel flow pattern, a
discontinuous or crowded pattern may develop
when several individual production area plants are
combined.
The flow of material and personnel through
corridors are inefficient and unsafe paths for
moving materials, particularly if heavy forklifts are
required.
22. x Design / Design
1 3
4 2
1 2
4 3
Discontinuous and crowed flow patterns
can decrease production efficiency, increase
security problems, and increase the problem of
maintaining a clean environment.
23. 6. UTILITES AND UTILITY EQUIPMENT LOCATION :-
Utilities :-
Piping system in particular, must be initially
and often periodically cleaned and serviced.
Exposed overhead piping is not acceptable from a
cleanliness or contamination stand point since it
collects dirt, is difficult to clean and may leak.
Buried or concealed pipe may require unacceptable
demolition for cleaning or repair.
Utilities equipment location :-
Public utilities require space for metering. In
addition to meeting, electrical power system
require for switchgear and transformer.
24. Water systems usually require treatment to
ensure consistent quality. Plant generated utilities
typically require steam boilers, air compressors, and
distillation, the typical “boiler room” approach.
Proper equipment maintenance is difficult in foul
weather, especially winter.
Heavy equipment may damage the roof-structure,
particularly if the equipment location
requires numerous penetrations through the roof
which, coupled with equipment vibration, will
invariable lead to leakage.
25. 7.Engineering and maintenance :-
From an engineering stand point, even a
location outside the plant can serve well if access to
the production area by engineers for field work is
not too difficult often particularly in small or less
complex plants, maintenance or other plant service
functions such as utilities or combined with
engineering, making an in-plant location desirable.
Maintenance responsibilities cover all areas
of the plant and can generally be grouped into two
categories: plant maintenance and production
maintenance.
26. 1) production maintenance is a direct production
support function and all the routine and recurring
operating maintenance work. Production
maintenance facilities are usually minimal, often
only a place to store a tool box, and seldom have
more than a small workbench.
2) plant maintenance operations, in contrast, are
more diverse. They vary from heavy maintenance
on production equipment to cosmetic work on the
building exterior and often include plant service
functions such as sanitation, ground sweeping, or
waste disposal.
27. LIST OF EQUIPMENTS (as per schedule-M):
The following equipments is recommended:
a)Manufacturing area :-
1. Storage equipment for ampoules, vials bottles and
closures.
2. Washing and drying equipment.
3. Dust proof storage cabinet.
4. Water still.
5. Mixing and preparation tanks or other containers.
6. Mixing equipment where necessary.
7. Filtering equipment.
8. Hot air sterilizer.
28. b) Aseptic filling and sealing room:-
9. Benches for filling and sealing.
10. Bacteriological filters.
11. Filling and sealing unit under laminar flow work
station.
C) General room:-
12. Inspection table
13. Leak testing table.
14. Labeling and packing benches.
15. Storage of equipment including cold storage and
refrigerators if necessary.
29. CONCLUSION
The parenteral route of
administration is the most effective route for the
delivery of the active pharmaceutical substances
with narrow therapeutic index, poor bioavailability
especially for those drugs, prescribed to
unconscious patients.
The present article describes that area
planning, facilities, design, construction and
manufacturing of sterile products. It is more
impartment to produce good quality of parenteral.
30. Parenterals are the pyrogen free liquids
these are manufactured and stored according to
cGMP guidelines. Proper area, environmental
control, personnel observation will gives excellent
parenteral products and attain their described
therapeutic effect.
31. REFERENCES
1. Industrial pharmacy (sterile products) by leon lachman,
657-659
2. Good manufacturing practices for pharmaceuticals 6th
edition, joseph D.nally, page no-37-113
3. Pharmaceutical science by remington, 12th edition, vol.1,
page.no-814-828
4. American journal of hospital pharmacy, vol.38, issue 8,
1144-114710. dispensing for pharmaceutical students;
5. www.fda.gov.
6. Drugs and cosmetics Act 1940.
7. www.GMP.online.coms
8. www.ispc.org